Marijuana Stocks (Live Ticker)
Want to learn how to invest in Marijuana Stocks?
You have 2 Options:
Option #1: Free Information Below
Continue scrolling through all the information we have provided you on hot to invest in cannabis stocks below, and attempt to figure it out all by yourself… (time-consuming).
Option #2: Cannabis College
Allow Learn Sativa University to guide you step-by-step.
If you are serious about investing in the cannabis industry, please click the button below in order to learn more about Florida Cannabis College.
We now offer turn-key solutions for those looking to open up a legal operation.
Learn Sativa University can help you with the following:
- Finding Investors
- Insider News
- How to Invest in the Right Cannabis Companies
- Medical Marijuana Business Plans
- Dispensary Licensing Pre-req’s
- MMTC Layouts
- Recruiting XP Marijuana Staff
- Locating DOH MMJ Doctors
- & Much, Much More.
Choose Your Path Below:
The 10 Most Popular Cannabis Stocks That You Should Be Watching
If you’re looking to begin investing in cannabis stocks, the time is ripe for a multitude of choices. 2019 has seen a significant fall in value across the board for the majority of top-ranking marijuana stocks; however, the chips are in place for a significant rally – especially when watching these cannabis stocks. Join us as take a look at the 10 most popular cannabis stocks and why they’re worth your attention.
Aphria is one of the largest cannabis producers in the world. This Ontario-based Canadian company is currently worth $7 billion and has ambitious plans for global expansion that has the potential to skyrocket its stock price.
Aphria’s current stock price is $4.79, which is a far cry from its all-time high of nearly $18 in January of 2018. However, don’t let this cascade in value turn you off just yet. As with all market cycles, there’s a boom and a bust period before real growth can occur. Let’s take a look at why $APHA is looking like such a strong choice for the upcoming months.
First, Aphria has become a global player in the cannabis scene by obtaining legal cannabis production licenses, distribution permits, and research facilities in Australia, Malta, South Africa, Italy, Germany, Denmark, Jamaica, Colombia, and Argentina.
Aphria’s global footprint is making waves and is seen as one of the few major cannabis producers to take advantage of other countries with emerging cannabis legislation. Currently, Aphria’s only rivals are Canopy Growth and Aurora, but this is kicking up Aphria’s competitiveness to corner the global market.
Although Aphria doesn’t produce the most cannabis, they are on track to secure larger facilities to make this increased demand a reality. With this in mind, it’s likely that sooner-than-later, Aphria will be capable of going head to head with Aurora and Canopy Growth in terms of sheer output.
If you’re concerned with their quality, then you’ll be pleased to know that Aphria is behind the outrageously popular Broken Coast brand. This craft cannabis brand has taken British Columbia by storm, and it’s one of the flagship subsidiaries of Aphria that exemplifies their dedication to quality for customers in Canada.
Global expansion, increased cannabis output, and a secure hold on craft cannabis brands – $APHA is an excellent choice when seeking cannabis stocks.
MedMen is a cannabis retail store chain that’s from California. They are known for their upscale approach to the cannabis dispensary scene and have drastically changed the way customers look at the retail experience of marijuana. MedMen goes a step further by also being a leading cannabis producer and advocate for the legal marijuana industry. Additionally, they’ve begun aggressive expansion into new cities to stamp their name across the USA.
MedMen’s stock has significantly decreased since its opening day in June 2018, where it found its all-time high at a whopping $5 per share. Now, it’s currently sitting at $1.10 at the time of writing. As with any stock that generates a significant amount of revenue, this low price isn’t likely to last.
MedMen is currently located throughout the United States, with 3 shops in Arizona, 12 locations in California, 13 in Florida (coming soon), 1 location in Illinois, 1 store in Massachusetts (coming soon), 4 stores in Nevada, and 4 locations in New York. With a total of 38 retail stores, MedMen is unlikely to be forgotten in the world of cannabis.
To make the case even juicier for MedMen, they recently partnered with the cannabis giant Cronos Group to expand into Canadian Markets. This new frontier may open massive opportunities for MedMen, which could potentially give a much-needed boost to its stock value.
Trulieve is a leading cannabis provider for medical patients in the state of Florida. Their business model has been exceptionally successful, and they’re on track to open their 30th retail location in Florida. They’re one of the few cannabis companies at the moment to remain steadily profitable – and even better – they’re expected to more than double their revenue.
Currently, Trulieve is sitting at roughly $10 at the time of writing, with a previous all-time high of $14.67 in April of this year. Although Trulieve hasn’t tumbled as hard as most other cannabis stocks, it’s likely due to its consistently strong performance over the last year and a half.
As long as Trulieve continues to gain a following in the Sunshine State, it will likely generate the revenue that investors want to see: green on top of green on top of green. Currently, Trulieve has already expanded to other states, including California, Massachusetts, and Connecticut, making it even more valuable as they enter new markets.
Flowr Corp ($FLWPF)
Flowr Corp. is a Canadian high-end cannabis producer for both recreational and medicinal markets. Flowr Corp. may be unknown to you, but this unknown marijuana stock may soon launch due to exciting partnerships and press releases.
Flowr Corp.’s market cap is currently $154 million, with a stock price of $2.34. Its previous all-time high was $7.26 in June of this year. Although this drastic value slide may scare off potential investors, it’s crucial to see why Flowr Corp. can rise above and beyond its previous ATH.
Flowr Corp. recently announced a flurry of groundbreaking news. First, they acquired a remaining 80% stake in Holigen Holdings, which owns grow facilities in Portugal and Australia. This was big news because this suddenly opens an entirely new market to Flowr Corp., as well as increased production capacity. Flowr Corp. expects an annual production capacity of 500,000 kilograms of cannabis, making it a force to be reckoned with in the global cannabis industry.
This new acquisition for Flowr Corp. is an early Christmas gift for any investor of this stock, and it’s likely that you’ll be hearing this name much more as we kick off the new year.
Innovative Industrial Properties ($IIPR)
Innovative Industrial Properties is a leading trust for real-estate investment opportunities in the cannabis industry. As you may know, cannabis production requires vast amounts of space to keep up with the growing demand for all marijuana products. Innovative Industrial Properties is a key business in turning real estate into fully operational cannabis facilities.
Additionally, Innovative Industrial Properties is one of the few cannabis companies that provides its investors with a dividend. This dividend stems from 90% of their taxable income, which is paid out on a quarterly basis. For most, this is a highly attractive investment opportunity with the dividend alone. However, Innovative Industrial Properties’ price is sitting at nearly the halfway mark of where it was in June of this year. Currently, $IIPR is worth $72 at the time of writing, and its previous all-time high was $130.
So, not only does this cannabis stock pay our quarterly dividends, but it’s also declined to the point that it’s becoming attractive to many investors looking for a stock to park their money for the next 2-5 years.
Charlotte’s Web ($CWBHF)
Charlotte’s Web is an American CBD producer that’s a leader in the cannabidiol market. Charlotte’s Web can be found in the majority of cannabis retail stores, as well as online. Now that hemp is legal in the United States, it can be expected that Charlotte’s Web will increase production to meet the growing demand for their CBD-infused products.
Charlotte’s Web is currently worth $500 million, which is a considerable amount for a CBD company. However, their worth is justified as CBD is beginning to catch on at the global level. Shares are currently pegged at $13.40, with a previous all-time high of $19.94 in June of this year.
Although Charlotte’s Web hasn’t fallen significantly in value, it’s surely a stock to keep an eye on as the FDA gears up to make an announcement regarding CBD regulations. Once this happens, Charlotte’s Web is adequately placed to take advantage since it has a first-mover advantage in the CBD market.
Canopy Growth Corp. ($CGC)
Ok, this list wouldn’t be complete without mentioning the world’s largest cannabis producer. Canopy Growth Corp. is a Canadian behemoth in the marijuana industry, and it’s only fair to discuss the potential benefits of holding this stock for years to come.
Canopy Growth has been in the crosshairs for many critics over the last year, mainly due to their issues with management. However, it can’t be denied that Canopy Growth is here to stay for the longer-term – especially when looking at their acquisitions and partnerships.
Recently, Canopy Growth announced that they were cleared to acquire Acreage Holdings, which is one of the largest investment funds for medicinal and recreational cannabis operations in the United States. Acreage holds a plethora of cannabis brands and marijuana stores under its umbrella, which means Canopy Growth will now give Acreage access to its products.
However, this massive deal (estimated to be $3.4 billion) is hinged on one condition – that the United States must legalize cannabis on the federal level to allow this acquisition to go through. Until then, the deal is on hold until there is legal clarity. However, for those that don’t wish to purchase the stock after the price rockets, they are comfortable buying at $20.30 per share at the time of writing.
Canopy Rivers ($RIV.V)
Canopy Rivers is a venture capital firm that specializes in the cannabis industry. Additionally, it maintains a strategic partnership with none other than Canopy Growth. This little known cannabis stock should be on your radar – especially because it’s business model dictates that it only makes small investments into a variety of public and private marijuana businesses.
Currently, worth $2.53 per share, Canopy Rivers shows strong potential to the upside – especially as it begins crawling back towards its previous all-time high of $5.30.
So far, Canopy Rivers has a portfolio of 17 companies that they currently invest in. Each of these companies is showing strong growth, making Canopy Rivers a smart stock to keep your eyes on.
Here it is, the cannabis producer that you’ve all been waiting to hear about. OrganiGram recently made headlines with elevated bacteria counts in the cannabis products. Since its all-time high in May this year of $7.24, it’s taken a severe tumble down over 50%. Currently, shares are trading at $3.56 at the time of writing.
However, analysts across the board are anticipating a major turnaround that will reward investors by the new year. OrganiGram only owns one production facility that incorporates a proprietary growth system that allows them to produce over 100-grams per plant. Their efficiency is crucial to their production capabilities when going toe-to-toe with major producers such as Canopy, Aurora, and Aphria. However, the biggest hint for a jump in value is due to OrganiGram’s profitability. It’s one of the few cannabis companies at the moment that’s generating consistent profits, which makes OrganiGram a leading choice of marijuana stocks.
To give you even more motivation regarding OrganiGram, they are to invest $15 million in technology to infuse chocolate. This investment is slated to coincide with Canada’s announcement that they are legalizing marijuana-based edibles, concentrates, and topicals beginning in December of this year.
By having innovative technology to infuse chocolate for edibles efficiently, OrganiGram is primed for liftoff as Canadian consumers begin indulging in marijuana edibles.
Green Thumb Industries ($GTBIF)
Last but not least, Green Thumb Industries is worth your attention. This company is a jack-of-all-trades, being a legal producer and a popular dispensary throughout the United States. They currently have 95 retail stores, 13 manufacturing facilities, and a headline acquisition of Integral Associates.
The acquisition of Integral Associates allows Green Thumb Industries to expand to the Nevada market – specifically Las Vegas. Currently trading at $9.04, this is a growing stock that is making the necessary moves to catapult it into the spotlight.
Investing in The Cannabis Industry
If you’re new to the investment arena, it’s ok – we’ve all been there. However, Investing in the cannabis industry has never been so easy. Currently, there are a plethora of options that will get you into the stock position of your choice. However, there are a few considerations to remember.
First, is the cannabis stock that you’re watching available to a US citizen? Many of the cannabis companies on the stock market are Canadian-based; however, many are listed on licensed stock exchanges in the US – such as NASDAQ. Sadly, some of the popular choices on this list are only available on Canadian stock exchanges, which makes them impossible to buy if you’re American.
Second, you’ll need to consider if you’ll invest with a brokerage or an online trading platform such as Robinhood. Using an online trading platform like Robinhood is incredibly easy to use, however, you’ll be the one making the trades. If you enjoy a hands-off approach, then contacting a brokerage may be your best option.
Once you’ve considered how you’ll purchase cannabis stocks, you’ll need to decide on which stocks to choose. At the same time, you’ll need to know how much you’ll invest. It’s essential to always remember the Golden Rule of investing: never invest more than you’re willing to lose. By doing your due diligence of each cannabis stock and investing a conservative sum is key to remaining out of harm’s way if a stock’s sentiment diminishes.
Ultimately, the cannabis stock market presents a host of opportunities for newbies and stock market veterans. With the cannabis industry poised for monumental growth on a global scale within the next decade, cannabis stocks are primed to potentially follow suit.
Additional Sources & References